You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DOTATATE

Showing 1 - 25 of 161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)

Completed
  • Neuroendocrine Tumor
  • Lutetium-177 DOTATATE
  • Houston, Texas
    Excel Diagnostics & Nuclear Oncology Center
Apr 16, 2023

Macrophage PET/CT Imaging Using 64Cu-DOTATATE for Diagnosis of

Recruiting
  • Cardiac Sarcoidosis
  • 64Cu-DOTATATE PET/CT scan
  • Copenhagen, Denmark
    Rigshospitalet
Nov 14, 2023

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

Not yet recruiting
  • Neuroendocrine Tumors
  • Somatostatin Receptor-positive Neuroendocrine Tumor
  • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin - Madison
Nov 2, 2023

Hepatocellular Carcinoma Trial in Birmingham ([68Ga]DOTATATE-PET/MRI)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Birmingham, Alabama
    University of Alabama at Birmingham Medical Center
Dec 16, 2022

Metastatic Neuroendocrine Tumor Trial (Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate)

Not yet recruiting
  • Metastatic Neuroendocrine Tumor
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Feb 10, 2023

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

Recruiting
  • Neuroendocrine Tumors (NET)
  • 68Ga-HA-DOTATATE PET/CT imaging
  • Calgary, Alberta, Canada
    Foothills Medical Center 1403 29 St NW
Jan 4, 2023

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Metastic Thyroid Cancer Trial run by the NIDDK (68-Gallium-DOTATATE-PET/CT)

Recruiting
  • Metastic Thyroid Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Neuroendocrine Tumors Trial (Lutathera)

Not yet recruiting
  • Neuroendocrine Tumors
  • (no location specified)
Aug 9, 2023

GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

Enrolling by invitation
  • GEP-NET
  • +3 more
  • Copenhagen, Denmark
    Rigshospitalet
Jan 24, 2023

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Neuroblastoma Trial in Montréal, Sherbrooke (Radiopharmaceutical 68Ga-DOTATATE)

Recruiting
  • Neuroblastoma
  • Radiopharmaceutical 68Ga-DOTATATE
  • Montréal, Quebec, Canada
  • +2 more
Jan 3, 2023

Atheroscleroses, Coronary Trial in Amsterdam (68Ga-Dotatate PET/CT)

Recruiting
  • Atheroscleroses, Coronary
  • 68Ga-Dotatate PET/CT
  • Amsterdam, Netherlands
    Academic Medical Center
Sep 8, 2022

Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Viscera
  • +4 more
  • Lutetium Lu 177 Dotatate
  • (no location specified)
Jan 25, 2023

Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

Not yet recruiting
  • Metastatic Midgut Neuroendocrine Tumor
  • Unresectable Midgut Neuroendocrine Tumor
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Mar 16, 2023

Meningioma Trial in Houston (Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography)

Recruiting
  • Meningioma
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 28, 2022

Meningioma Trial in Vandœuvre-lès-Nancy (Everolimus)

Not yet recruiting
  • Meningioma
  • Vandœuvre-lès-Nancy, Grand Est, France
  • +1 more
Nov 8, 2023

Head & Neck Cancer Trial in Toronto (PET/MRI of carotid arteries with 68Ga DOTATATE)

Recruiting
  • Head & Neck Cancer
  • PET/MRI of carotid arteries with 68Ga DOTATATE
  • Toronto, Ontario, Canada
    University Health Network
Oct 31, 2022

Coronary Arteriosclerosis Trial in Paris (injection of 68Ga-DOTATATE)

Terminated
  • Coronary Arteriosclerosis
  • injection of 68Ga-DOTATATE
  • Paris, France
    service de médecine nucléaire-Hôpital Bichat
Jun 29, 2022

Diabetes, Type 2, Vascular Inflammation Trial in Amsterdam (Atorvastatin 40 Mg Oral Tablet)

Completed
  • Diabetes Mellitus, Type 2
  • Vascular Inflammation
  • Atorvastatin 40 Mg Oral Tablet
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location AMC
Feb 7, 2023

68-Ga DOTATATE PET/MRI in Diagnosis and Management of

Recruiting
  • CNS Tumors
  • +6 more
  • Ga68-DOTATATE-PET/MRI
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2022

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023